-+ 0.00%
-+ 0.00%
-+ 0.00%
Daito Pharmaceutical Revises Executive Responsibilities Effective Dec. 1
Share
Listen to the news
Daito Pharmaceutical Revises Executive Responsibilities Effective Dec. 1
  • Daito Pharmaceutical announced management changes Nov. 11, 2026, effective Dec. 1, 2026, as part of an organizational restructuring.
  • Toru Ishida will relinquish his concurrent role as head of the environmental safety office.
  • Yoshinori Nakajima will become head of the production management division, moving from head of the production management department.
  • Eiichi Takada will become head of purchasing, replacing his role as head of purchasing and logistics.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Daito Pharmaceutical Co. Ltd. published the original content used to generate this news brief on November 11, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending